Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21405,190,1.19 [0.87-1.64],0.2841289251876722
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22590,243,1.02 [0.76-1.37],0.9022386171569844
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22316,1722,1.08 [0.97-1.21],0.1450655574967007
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Candidiasis,22596,530,0.86 [0.70-1.06],0.1583832402910845
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21851,4132,1.03 [0.96-1.11],0.3593426176733005
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21797,4217,1.03 [0.95-1.10],0.4853730549363211
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22311,1393,1.05 [0.93-1.18],0.4614727569584147
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22502,128,1.27 [0.87-1.85],0.2191558815673376
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19829,1266,1.13 [0.99-1.28],0.0635954074293766
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19135,1546,1.17 [1.04-1.31],0.0082514719560006
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,18644,328,0.93 [0.72-1.22],0.6169941450510465
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14698,2680,1.04 [0.95-1.14],0.3765310241085566
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18592,486,1.14 [0.93-1.40],0.2216688287160843
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22571,1653,1.03 [0.92-1.15],0.6358140852713797
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Mycoses,22686,620,0.92 [0.76-1.11],0.372850494473836
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21813,1219,1.09 [0.95-1.24],0.2144059618995941
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22614,1399,1.13 [1.00-1.27],0.0427853052353404
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21161,243,1.02 [0.76-1.38],0.8861316837789345
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,22744,64,1.03 [0.58-1.82],0.9320145248806432
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22437,1222,1.15 [1.01-1.30],0.034960270083691
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22449,75,0.86 [0.49-1.49],0.5869350444794494
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other viral diseases,22681,136,1.08 [0.73-1.60],0.6996292731701137
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22660,115,1.21 [0.80-1.82],0.3615791868663484
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21087,493,1.03 [0.83-1.26],0.8060378236338517
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,20895,301,1.06 [0.82-1.38],0.651334519620055
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21053,135,0.93 [0.62-1.41],0.7424144518944646
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,22729,51,1.01 [0.53-1.92],0.9669950294309736
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,22675,168,1.12 [0.79-1.58],0.5375065173204707
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral warts,22560,53,1.28 [0.71-2.31],0.406046608505421
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],22584,77,1.21 [0.74-1.99],0.4520057289826183
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm,22454,261,0.98 [0.74-1.31],0.8986426089156464
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,22662,40,1.03 [0.50-2.16],0.9286576987734944
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,22645,44,1.47 [0.80-2.69],0.2157669645282167
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10850,84,1.28 [0.81-2.03],0.2843016174226995
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22295,1635,0.91 [0.81-1.02],0.1164068047815633
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of meninges,22729,64,1.25 [0.73-2.12],0.4124612400702899
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,22648,79,0.92 [0.54-1.57],0.7567706330667456
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,22717,117,0.92 [0.59-1.42],0.6988029477545261
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of ovary,11826,78,0.92 [0.53-1.57],0.7483965640562741
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Ascending colon,22706,430,0.87 [0.69-1.09],0.2301822240156235
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Caecum,22710,377,0.89 [0.70-1.14],0.3453635853385478
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22602,85,0.94 [0.56-1.57],0.8212901868096772
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Descending colon,22701,248,0.74 [0.55-1.01],0.0615569541391564
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Rectum,22662,402,0.76 [0.60-0.97],0.0278581709026759
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22597,652,0.90 [0.75-1.09],0.2844693541108424
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Transverse colon,22688,525,0.89 [0.72-1.09],0.264481267190446
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Carcinoma in situ of breast,8895,49,0.92 [0.47-1.81],0.8092068183301804
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",8935,64,1.08 [0.62-1.89],0.7905775053274344
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16237,71,0.96 [0.55-1.68],0.8884079417338614
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16263,97,1.01 [0.63-1.63],0.9721104074110823
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",22688,124,0.89 [0.58-1.37],0.5916103927588627
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma, any site",22689,121,0.87 [0.56-1.35],0.5325296031749411
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Leiomyoma of uterus,11560,165,0.78 [0.53-1.15],0.2130011869026143
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Lung cancer and mesothelioma,14378,471,1.25 [1.01-1.53],0.0362750897493634
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Lymphoid leukaemia,16239,73,0.81 [0.46-1.43],0.4599234159952553
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16387,221,1.08 [0.80-1.48],0.6088359988167583
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16478,312,0.87 [0.66-1.14],0.3172866037836339
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9015,102,0.88 [0.55-1.42],0.6045500156544813
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16271,105,0.95 [0.60-1.50],0.8250944543419345
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16311,145,1.27 [0.88-1.83],0.194825267749207
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16290,124,0.61 [0.39-0.97],0.0353106678605938
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",8996,83,0.96 [0.58-1.61],0.8897723476782406
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16291,125,0.95 [0.62-1.45],0.8037465680017893
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8206,953,1.03 [0.89-1.20],0.7039885154664323
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16302,136,1.18 [0.80-1.73],0.3986880399067188
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16256,90,0.86 [0.51-1.42],0.5488450261974859
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16307,141,1.36 [0.94-1.95],0.0988920193448693
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi,22601,179,0.98 [0.70-1.39],0.925956783443428
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi of trunk,22716,76,1.02 [0.61-1.71],0.9424639387328966
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanoma in situ,16217,107,1.23 [0.80-1.89],0.3474972419727486
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16283,117,1.08 [0.71-1.66],0.7131410480526279
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16360,194,1.17 [0.85-1.61],0.3408413827083594
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16487,321,1.06 [0.82-1.37],0.6588841202410138
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16290,124,1.24 [0.84-1.82],0.287382850750156
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Other benign neoplasms of skin,22574,161,0.97 [0.67-1.40],0.8720287689603924
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17629,1463,0.98 [0.87-1.11],0.8019658226279607
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17710,1544,0.98 [0.86-1.10],0.6827949464765036
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22439,384,0.97 [0.76-1.23],0.7785654002508915
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20469,163,1.29 [0.92-1.81],0.1398711535036961
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22122,67,1.17 [0.68-2.00],0.5749130520892549
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21989,3427,0.90 [0.83-0.98],0.0128439391367784
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21050,70,0.57 [0.31-1.05],0.0712369883057827
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22288,62,1.05 [0.58-1.88],0.8738916889258714
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22243,1937,0.89 [0.80-0.99],0.0365488734633217
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22241,1935,0.89 [0.80-0.99],0.0372706274124156
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20418,112,0.87 [0.56-1.37],0.5569173597790371
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22389,1409,0.96 [0.85-1.09],0.5341033811353658
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22332,106,0.79 [0.49-1.27],0.3285171957176167
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22132,77,0.98 [0.58-1.66],0.9433322175291388
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22130,75,0.66 [0.37-1.17],0.1565611795277734
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,22571,345,1.28 [1.02-1.61],0.0309443127015515
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,22618,39,1.60 [0.88-2.92],0.1211925179944374
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22508,282,1.29 [1.00-1.66],0.0457019206349923
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21115,135,0.70 [0.46-1.07],0.1014114406701888
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15224,412,1.03 [0.82-1.29],0.7937012071510492
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21253,102,0.88 [0.55-1.41],0.6074246446138905
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21262,111,1.28 [0.79-2.08],0.322138039600901
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14881,69,1.50 [0.94-2.39],0.0860135913665398
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21118,64,0.63 [0.33-1.19],0.156631243189546
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20346,309,0.99 [0.76-1.29],0.9213326434433644
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",21953,938,1.05 [0.90-1.22],0.5665571925336359
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21497,482,1.13 [0.91-1.39],0.2626879152296664
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21231,216,0.91 [0.66-1.26],0.56817777826293
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22459,1405,0.95 [0.84-1.08],0.4308586664408306
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19124,1362,0.96 [0.85-1.10],0.578495496557073
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14899,87,1.15 [0.72-1.83],0.5582082606182363
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20482,99,1.01 [0.63-1.60],0.9768459216769252
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15179,367,1.10 [0.87-1.39],0.4403655925936873
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14865,53,1.27 [0.72-2.24],0.4046229518718716
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19307,4495,0.96 [0.89-1.03],0.2235212764831534
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15074,262,1.12 [0.85-1.48],0.4036115348959355
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15516,704,1.07 [0.90-1.27],0.4209614588508125
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22687,365,1.11 [0.88-1.41],0.3769961434029806
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22482,160,1.31 [0.93-1.83],0.1196626240246652
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14964,152,1.03 [0.71-1.49],0.8854336557623407
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14894,82,0.93 [0.55-1.55],0.7730104596673348
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22110,1727,0.95 [0.85-1.06],0.3578774189203373
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15188,376,1.21 [0.97-1.52],0.0945136691586148
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15227,415,1.01 [0.81-1.27],0.9261533023486612
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15660,848,0.87 [0.74-1.02],0.0916529451896268
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14982,170,1.05 [0.74-1.48],0.7991020212662734
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22472,150,1.44 [1.03-2.01],0.0327876484267013
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15696,884,0.95 [0.81-1.11],0.508861378978591
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15459,647,0.94 [0.78-1.13],0.4854887354422024
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20115,78,1.26 [0.78-2.02],0.3468075648755134
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21112,6300,0.98 [0.93-1.04],0.5460473249057164
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20442,59,1.01 [0.55-1.83],0.9848099910115734
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20434,51,0.97 [0.50-1.87],0.9207234866794316
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22560,1883,0.90 [0.81-1.00],0.0610263721595948
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22558,1881,0.90 [0.81-1.00],0.0568572387150851
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20449,66,0.52 [0.27-0.98],0.043071071444389
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22394,1127,1.01 [0.88-1.16],0.8442271364766939
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17019,2207,1.02 [0.92-1.12],0.745339766099254
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,22729,305,1.06 [0.82-1.37],0.675701495534961
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21144,129,1.37 [0.94-2.00],0.1035950366659043
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21383,116,1.12 [0.74-1.72],0.5873954939469568
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21429,162,1.03 [0.71-1.48],0.8839014318002316
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15009,197,1.04 [0.75-1.44],0.817492901882978
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,19984,176,0.83 [0.57-1.19],0.3007893566119625
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2437,97,0.71 [0.43-1.18],0.1899419434277014
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2603,303,0.84 [0.63-1.11],0.2191093376857036
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,19892,84,1.28 [0.84-1.96],0.2530582541982991
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2413,76,0.86 [0.49-1.49],0.5864459986042754
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21913,2105,1.12 [1.02-1.24],0.0189850380252288
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,21638,623,1.10 [0.91-1.32],0.3221192308144776
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20479,442,0.96 [0.77-1.20],0.7396170504557799
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15907,1095,0.87 [0.75-1.01],0.0597139286064845
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22609,298,0.99 [0.76-1.30],0.9706057909443376
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21265,265,0.98 [0.74-1.31],0.8935460866875549
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Angina pectoris,19643,1554,1.00 [0.89-1.13],0.9710120836790708
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21369,369,0.99 [0.77-1.26],0.9077087663094234
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21084,84,0.92 [0.55-1.55],0.7603981025209501
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21283,283,0.88 [0.66-1.17],0.3751102379638212
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11516,2793,1.06 [0.97-1.16],0.1764511213893251
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,AV-block,17286,660,0.98 [0.81-1.17],0.7920391485847943
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22664,580,1.00 [0.82-1.21],0.9902903695818004
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiac arrest,8984,261,1.08 [0.81-1.43],0.6180891553554717
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16822,196,1.18 [0.86-1.62],0.298927921897067
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16732,106,1.10 [0.71-1.70],0.6793327298592637
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,22740,79,1.06 [0.62-1.80],0.826864069881927
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Conduction disorders,18143,1517,1.02 [0.90-1.14],0.7944537445083781
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20778,2714,1.05 [0.97-1.15],0.2383867611191315
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18240,8741,0.99 [0.94-1.04],0.6154341254304149
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21196,328,1.01 [0.78-1.31],0.9349118015495048
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Endocarditis,16726,100,1.26 [0.81-1.94],0.3008795954350973
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22457,1633,1.19 [1.07-1.33],0.0015284913574686
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertension,19459,7782,1.01 [0.96-1.07],0.6056306351427838
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19480,7803,1.01 [0.96-1.07],0.631845436191043
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22575,94,0.89 [0.55-1.45],0.6456071721479361
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",11934,257,1.31 [1.01-1.71],0.0451335519592926
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,11882,205,1.11 [0.81-1.52],0.5223297887560896
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypotension,22563,1611,1.01 [0.90-1.14],0.8110372499553821
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21471,142,0.75 [0.49-1.14],0.1755907390610906
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20951,2862,1.04 [0.96-1.13],0.3570408597966037
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22237,783,0.95 [0.80-1.12],0.52880855879568
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17141,515,1.24 [1.02-1.50],0.0294760018924694
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22059,1039,1.04 [0.90-1.20],0.6193799335558468
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",18983,894,1.02 [0.88-1.19],0.7592679900838166
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22616,182,1.04 [0.73-1.46],0.844084275957992
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",22699,397,0.93 [0.73-1.17],0.5178179606901216
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Oesophageal varices,20931,63,0.99 [0.55-1.79],0.9748377844496008
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other aneurysm,21104,104,1.20 [0.78-1.84],0.4071682754944133
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arrhythmias,17217,591,1.06 [0.88-1.28],0.5668690187275625
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21131,131,0.84 [0.55-1.29],0.4257818979839671
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21320,320,1.03 [0.80-1.34],0.7951032788829181
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,16850,224,1.33 [1.01-1.76],0.0425855479233704
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other disorders of veins,20987,119,1.04 [0.68-1.58],0.8538363021456683
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,20914,46,1.40 [0.75-2.61],0.2913215135578375
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,20721,89,0.75 [0.45-1.27],0.2844222673682725
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21044,176,0.91 [0.63-1.29],0.5853884864472884
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18062,1436,0.96 [0.85-1.09],0.5714741151599863
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21012,60,1.06 [0.59-1.90],0.8546267324022621
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21724,724,0.90 [0.75-1.08],0.2470975381848503
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,21973,520,1.35 [1.13-1.62],0.0012766316747054
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",21601,969,0.92 [0.79-1.08],0.3020603158402607
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9135,412,1.07 [0.86-1.34],0.5469177976816884
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21554,589,0.91 [0.75-1.11],0.3670862846531421
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21278,410,0.91 [0.72-1.15],0.4276309483336085
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22051,598,1.08 [0.90-1.31],0.3939789223051171
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22646,948,1.02 [0.87-1.18],0.831912965902851
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17129,503,0.96 [0.78-1.19],0.7371273612806708
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Secondary right heart disease,21966,513,1.39 [1.15-1.66],0.0004565423305129
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,20892,260,0.86 [0.64-1.16],0.3111283001051972
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22221,892,0.91 [0.78-1.07],0.2602817811616383
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22206,928,0.92 [0.79-1.08],0.3030154176882629
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21442,58,1.00 [0.54-1.85],0.9926810809640844
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21105,105,0.84 [0.52-1.35],0.4655943506870181
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Transient ischemic attack,21768,314,1.04 [0.80-1.35],0.7571584663804465
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21346,326,1.06 [0.82-1.36],0.6688676080754383
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Varicose veins,21382,514,0.85 [0.69-1.05],0.1391249458186446
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21021,120,0.85 [0.55-1.33],0.4800073502976598
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22464,933,1.00 [0.86-1.17],0.9866738281024656
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22661,330,0.88 [0.67-1.14],0.3350383289091696
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19419,1371,1.02 [0.90-1.15],0.8000451213318944
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Any mental disorder,22216,4168,1.02 [0.95-1.10],0.5958772370144618
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22632,389,0.98 [0.77-1.24],0.8775987066618057
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19481,1433,0.96 [0.85-1.09],0.5307783677615221
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18132,84,1.06 [0.64-1.75],0.8108878763568392
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Smoking dependency,22238,1167,1.12 [0.98-1.29],0.1093217266558182
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19484,1436,1.05 [0.94-1.19],0.3725173588476135
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Vascular dementia,21848,228,0.96 [0.70-1.32],0.7925660560965782
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Alzheimer disease,22740,590,1.10 [0.91-1.33],0.3288811493080996
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",13915,111,0.98 [0.62-1.54],0.9265333997072516
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Bell's palsy,20920,84,0.57 [0.32-0.99],0.0466231769593116
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21319,483,0.88 [0.71-1.10],0.2569989048450599
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral cysts,22301,244,0.82 [0.60-1.12],0.2032276628822379
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22669,404,0.73 [0.57-0.93],0.0121988555679945
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,21894,75,1.38 [0.86-2.21],0.1771351369953749
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,22724,67,0.67 [0.37-1.24],0.2007620419525458
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22142,85,1.02 [0.61-1.69],0.949394487085058
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Epilepsy,21256,301,0.68 [0.51-0.91],0.0088092302001823
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22280,1325,0.91 [0.80-1.03],0.1427198839302505
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,22688,916,0.90 [0.77-1.05],0.187146140224381
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22088,3413,0.95 [0.88-1.03],0.2254672330272891
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Generalized epilepsy,22360,52,1.27 [0.70-2.32],0.4297180184054441
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hemiplegia,22593,328,0.78 [0.59-1.02],0.0650116007775253
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hydrocephalus,22132,75,1.03 [0.60-1.76],0.9173000771628408
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,22727,74,1.33 [0.81-2.17],0.2646927156681821
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,20902,66,1.18 [0.68-2.05],0.5500266017598241
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,20904,68,1.34 [0.80-2.23],0.2607967233620943
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Memory loss,21598,140,0.92 [0.62-1.38],0.6963918034966623
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Migraine,21227,272,0.92 [0.69-1.23],0.5934450090990087
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22693,248,0.88 [0.65-1.20],0.4149958094332481
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Motor neuron disease,14001,175,0.90 [0.63-1.30],0.5786863386608025
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,22612,61,1.01 [0.56-1.84],0.9745190096762868
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22038,1202,1.00 [0.88-1.15],0.9769029330003932
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Neurological diseases,21270,4301,0.96 [0.90-1.03],0.2909570207939007
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22139,320,0.76 [0.58-1.01],0.0546517290000448
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21252,416,1.07 [0.86-1.34],0.5302893346367702
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",22665,344,1.18 [0.93-1.49],0.1752155572138492
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16994,971,0.99 [0.84-1.15],0.8476582144260127
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22140,83,1.33 [0.85-2.08],0.2193868534065672
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22216,159,0.69 [0.47-1.03],0.0699226161607751
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22000,228,0.88 [0.64-1.22],0.4449628457281998
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other facial nerve disorders,20930,94,0.56 [0.33-0.95],0.0307475362769509
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other headache syndromes,21008,53,0.95 [0.50-1.80],0.8801138245679164
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other neurological diseases,22630,573,0.96 [0.79-1.16],0.6598294640734206
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other sleep disorders,21465,510,0.99 [0.81-1.22],0.9433992562838482
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Parkinson's disease,22709,686,0.91 [0.76-1.09],0.3014575343748336
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22101,44,0.62 [0.29-1.34],0.2220932312204428
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Restless leg syndrome,22741,104,1.00 [0.63-1.58],0.9846642925305426
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Sleep apnoea,22511,431,1.03 [0.82-1.28],0.8164148189315379
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22378,57,1.03 [0.56-1.91],0.9236266030872852
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,22729,202,0.96 [0.69-1.34],0.8322219678828304
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,20904,68,0.94 [0.53-1.67],0.8278637413762377
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,22740,596,1.09 [0.90-1.32],0.3792699301908808
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),21786,222,0.96 [0.70-1.32],0.7994748781355258
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22114,151,0.92 [0.62-1.35],0.6657281463560799
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22292,551,0.71 [0.57-0.88],0.0014641195213739
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22487,262,0.96 [0.72-1.28],0.7858355879842527
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21530,67,0.83 [0.46-1.51],0.5451151882451478
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21500,37,0.98 [0.46-2.10],0.956531331711878
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",22620,73,0.75 [0.42-1.34],0.3263845653953746
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22424,220,0.63 [0.45-0.89],0.0084231341603834
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2417,77,0.84 [0.48-1.46],0.540745890265206
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2980,112,0.80 [0.51-1.28],0.3571582613301397
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22065,102,1.17 [0.76-1.81],0.4718127165559221
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22447,1401,1.00 [0.88-1.13],0.957738367063028
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22330,867,0.90 [0.76-1.06],0.1966718603624157
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,21759,296,1.11 [0.85-1.44],0.4307738656245612
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22668,927,0.82 [0.70-0.96],0.0136806800870307
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,22734,82,0.85 [0.50-1.45],0.548226675241373
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,22600,859,0.82 [0.70-0.97],0.0227660624444978
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",22700,496,0.77 [0.62-0.96],0.0200126238961685
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,22623,221,0.86 [0.62-1.19],0.3730779520583466
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,21561,98,0.99 [0.62-1.58],0.9624984341723456
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,21563,100,0.87 [0.53-1.40],0.5574706692677595
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21534,71,0.71 [0.39-1.28],0.2533699031512533
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22604,992,1.05 [0.91-1.22],0.5039468144406429
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,21867,255,1.14 [0.86-1.51],0.3497818732734912
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,21810,69,1.69 [1.10-2.59],0.0172459097995507
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22324,120,0.84 [0.54-1.30],0.4294718113323909
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,22592,388,0.74 [0.58-0.96],0.021791211751652
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,21957,216,0.84 [0.60-1.17],0.3055097117059437
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22539,137,0.75 [0.49-1.15],0.1900936376534819
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22274,662,1.06 [0.89-1.27],0.5259771205311963
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22121,158,1.01 [0.70-1.46],0.960366118053108
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20330,3202,1.02 [0.94-1.11],0.5921868977623757
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,22546,342,0.72 [0.55-0.95],0.0186766611889357
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,22730,182,1.10 [0.78-1.53],0.5927394941384231
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,21991,528,0.90 [0.73-1.11],0.3392395096190957
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22293,89,0.84 [0.50-1.40],0.4919611862862353
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,22725,73,0.86 [0.49-1.51],0.5997473580801831
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,21590,127,0.82 [0.53-1.27],0.3734882508398514
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,21636,173,0.68 [0.47-1.00],0.0497139299633498
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21209,163,1.13 [0.79-1.61],0.5007542471455667
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,21802,61,0.85 [0.46-1.58],0.60918990705896
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21117,71,1.28 [0.76-2.16],0.3438322725400617
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,21725,113,0.71 [0.44-1.15],0.1649170918434523
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",21899,287,1.11 [0.85-1.46],0.4384998081161106
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,21621,158,0.99 [0.68-1.43],0.9418796702695124
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21142,96,0.80 [0.49-1.32],0.3833829978649835
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21178,132,0.72 [0.47-1.12],0.1450947423293483
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19823,2695,0.94 [0.86-1.03],0.1810669131044435
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21551,88,0.99 [0.60-1.62],0.953794985071543
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22456,493,1.02 [0.82-1.25],0.8812613034996212
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22040,77,1.13 [0.67-1.88],0.6512060813073628
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22162,199,0.94 [0.68-1.32],0.7399820963999044
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22524,110,1.09 [0.71-1.68],0.6934585815619825
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,22697,140,0.74 [0.48-1.12],0.153752353391787
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,22607,119,0.65 [0.41-1.03],0.0658258571779642
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22477,63,1.05 [0.59-1.88],0.8743325759155338
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,22481,67,1.28 [0.77-2.14],0.3350210319906572
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,22633,1227,0.89 [0.78-1.03],0.1102738849475536
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22334,928,0.91 [0.78-1.06],0.2193095782876697
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,21559,153,0.96 [0.66-1.39],0.8133334119809001
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21492,86,0.89 [0.53-1.49],0.6517312074367932
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute pharyngitis,22553,65,0.76 [0.41-1.39],0.3688862120706048
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22670,182,0.72 [0.50-1.05],0.0850087560008568
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22548,60,0.75 [0.40-1.41],0.3724632132227907
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,All influenza,20110,156,1.57 [1.15-2.14],0.0043938126974929
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20107,153,1.58 [1.15-2.15],0.0042744629391193
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14009,102,0.79 [0.48-1.29],0.3499863480925582
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Allergic rhinitis,22635,232,0.99 [0.73-1.33],0.9273039856508366
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15201,1673,0.98 [0.88-1.10],0.7705671420875261
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15558,1651,1.00 [0.89-1.13],0.9563186448460976
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22233,175,1.34 [0.98-1.84],0.0680176455079464
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20056,102,1.45 [0.97-2.15],0.0672998656643262
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Bronchiectasis,19071,507,1.26 [1.04-1.52],0.0173078559290154
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",18635,71,1.49 [0.94-2.36],0.0911984658655425
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21627,3063,0.99 [0.91-1.08],0.8785986786053561
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21538,72,1.19 [0.71-1.99],0.5020892322221344
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic sinusitis,21596,130,1.23 [0.85-1.79],0.278220960063355
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22453,1605,0.96 [0.86-1.08],0.5373838475825414
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Deviated nasal septum,21543,77,1.06 [0.63-1.78],0.8163038670870914
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20622,5997,1.01 [0.95-1.07],0.766288651771138
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",21798,332,1.00 [0.77-1.29],0.984285662068135
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Early onset COPD,20953,105,1.26 [0.85-1.88],0.2536066428093477
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Emphysema,18987,423,1.11 [0.89-1.38],0.3435460583468337
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21468,441,1.31 [1.07-1.60],0.0087408085020671
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22492,2538,1.13 [1.04-1.24],0.00623880831778
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Interstitial lung disease,21509,482,1.26 [1.03-1.53],0.0225417459992681
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Later onset COPD,22226,1500,0.94 [0.83-1.06],0.3331019819973563
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,22724,490,1.03 [0.84-1.27],0.7648927243260379
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Nasal polyp,21556,90,1.07 [0.66-1.73],0.7918239029272978
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22458,1278,1.21 [1.07-1.37],0.0028275934842209
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of pleura,22454,2645,1.08 [0.99-1.18],0.1020124196674391
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22201,735,1.00 [0.85-1.19],0.9772158840718358
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other pleural conditions,19874,65,1.29 [0.77-2.18],0.3342488643945492
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22618,575,1.28 [1.07-1.53],0.0066860717911994
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22615,1691,1.02 [0.91-1.14],0.7603662419520022
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural effusion,21163,1354,1.15 [1.02-1.30],0.0196901186718698
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural plaque,20057,248,1.12 [0.84-1.49],0.4260863912312032
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22206,2252,1.11 [1.01-1.22],0.0298021976323827
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,22614,380,1.09 [0.86-1.38],0.4693331348911411
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pneumothorax,19976,167,1.15 [0.82-1.62],0.4128828477896294
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pollen allergy,22731,198,0.99 [0.72-1.38],0.975495000229902
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pulmonary oedema,22131,88,1.81 [1.24-2.64],0.0020359114214496
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13977,70,1.13 [0.66-1.94],0.6648577375590452
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22435,1255,1.21 [1.07-1.38],0.0022851373624905
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,21700,234,0.96 [0.71-1.30],0.8047863748665774
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Viral pneumonia,20252,298,1.04 [0.80-1.36],0.7628155742627305
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22241,239,1.05 [0.78-1.41],0.7398504963824665
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7235,119,0.91 [0.59-1.42],0.686431794937291
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14411,59,1.29 [0.76-2.21],0.3442828590152033
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute appendicitis,22631,126,0.74 [0.48-1.15],0.1804586140347778
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute gastritis,15820,105,1.08 [0.69-1.69],0.7234477771504086
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute pancreatitis,20729,195,1.14 [0.82-1.58],0.4276758379778645
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute peritonitis,22263,102,1.50 [1.01-2.22],0.0421520873070319
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Alcoholic liver disease,21781,62,0.74 [0.40-1.38],0.3469761623938985
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Barrett oesophagus,16218,503,0.76 [0.61-0.95],0.0146357792920766
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",20682,148,1.15 [0.80-1.67],0.4413439061421497
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22329,148,1.16 [0.80-1.67],0.4386734040935803
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholecystitis,20754,220,1.29 [0.97-1.73],0.085137292374643
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholelithiasis,21569,1035,1.06 [0.92-1.23],0.4023805884503085
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic gastritis,16064,349,0.86 [0.67-1.12],0.2614255917214777
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic pancreatitis,20590,56,0.37 [0.18-0.74],0.0050424498929722
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22605,124,1.00 [0.66-1.51],0.9843892786320608
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Coeliac disease,21030,124,0.67 [0.43-1.06],0.0874144168604201
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Collagenous colitis,21027,101,0.66 [0.40-1.09],0.1067792195083268
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22624,152,0.94 [0.64-1.38],0.7558782694894275
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Constipation,22457,2091,0.88 [0.79-0.98],0.0191801906464336
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn disease,21013,87,0.98 [0.59-1.62],0.9393578521926302
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22397,67,0.98 [0.56-1.74],0.9534122404234756
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21005,79,1.11 [0.66-1.84],0.6975747313741767
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Dental caries,22139,184,0.96 [0.68-1.35],0.7936700809709711
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19624,2519,0.92 [0.84-1.01],0.0833987852183847
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of appendix,22660,155,0.73 [0.49-1.09],0.125161562565159
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of liver,22620,901,1.02 [0.87-1.19],0.8186641314222585
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20215,4500,0.90 [0.84-0.97],0.0053845193464103
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22414,459,0.92 [0.74-1.15],0.4752935899526745
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22654,493,1.11 [0.91-1.36],0.3121128886585698
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22045,90,0.72 [0.43-1.21],0.2171739205379001
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of salivary glands,21923,58,0.95 [0.51-1.77],0.8732984251077882
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22407,1501,0.95 [0.84-1.07],0.3899021718076453
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of tongue,21940,94,0.97 [0.59-1.57],0.8885257026879843
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22034,1500,1.00 [0.88-1.12],0.9531075756266568
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18082,3730,0.94 [0.87-1.02],0.1232018863227019
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Duodenal ulcer,15960,245,0.80 [0.59-1.09],0.1595505684211159
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22648,200,0.73 [0.51-1.03],0.0735256957886067
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,22707,27,1.57 [0.76-3.22],0.222351066231987
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,21865,146,0.89 [0.60-1.32],0.5694773910272866
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14456,104,0.99 [0.63-1.57],0.9822403484528964
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Functional dyspepsia,16275,560,0.78 [0.63-0.96],0.0175966536685106
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastric ulcer,16141,426,0.89 [0.71-1.12],0.3218400742131622
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18327,2612,0.87 [0.80-0.96],0.0045819699992125
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16363,648,0.86 [0.71-1.04],0.1113667688668057
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16417,8063,0.95 [0.90-1.00],0.0462030516162116
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,GI-bleeding,22153,1247,0.94 [0.82-1.07],0.3543394551597508
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,21999,44,0.81 [0.39-1.69],0.5747430776213436
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15323,1158,0.91 [0.79-1.05],0.1855445664270918
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",21785,66,0.75 [0.41-1.38],0.3609764424237696
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Hernia,20709,3604,0.95 [0.88-1.03],0.1987242255200499
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impacted teeth,22711,25,1.58 [0.75-3.31],0.228103760639848
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impaction of intestines,14431,79,1.89 [1.30-2.74],0.0007894932596779
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Inguinal hernia,18191,1086,1.03 [0.90-1.18],0.677779082824931
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17225,120,0.91 [0.60-1.40],0.682409999372861
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14466,114,0.97 [0.63-1.49],0.8844109524444957
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21049,143,0.78 [0.52-1.18],0.2387437495744284
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14858,506,0.86 [0.69-1.07],0.1688031596514758
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,22708,331,1.01 [0.79-1.30],0.9244980335008826
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,21701,775,1.07 [0.90-1.26],0.4436754879329952
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22000,1074,0.98 [0.85-1.13],0.7570479345960487
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15933,218,0.78 [0.56-1.09],0.1434011584142108
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophagitis,16405,690,0.71 [0.59-0.86],0.0003558773527
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,22686,135,1.15 [0.79-1.67],0.4759077318482008
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17192,87,0.97 [0.59-1.59],0.9032246217222508
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15704,1352,0.96 [0.85-1.09],0.5758658214331829
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,20892,358,1.03 [0.80-1.31],0.833143091874765
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,20674,140,1.01 [0.68-1.49],0.9701195291908452
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestine,16256,1904,0.96 [0.86-1.07],0.4612593642718989
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestines,20461,6109,0.94 [0.88-1.00],0.042492259241161
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,21899,211,0.99 [0.72-1.36],0.959334408782887
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of liver,22464,745,1.07 [0.90-1.26],0.4446726387886325
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16469,754,0.82 [0.69-0.98],0.026965924919842
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of pancreas,20747,213,0.88 [0.63-1.22],0.4350985896058659
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22582,421,1.04 [0.83-1.30],0.7479672725971032
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16786,1071,0.86 [0.74-1.00],0.0428081205844543
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22169,1263,0.95 [0.83-1.09],0.4525884031480887
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22122,167,0.79 [0.54-1.15],0.2120989286730875
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16487,2135,0.87 [0.79-0.97],0.0111833134164025
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17838,2123,0.96 [0.86-1.06],0.384632283330049
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,21828,109,0.96 [0.62-1.49],0.8547855348464514
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,21871,945,0.99 [0.85-1.16],0.9335421672758768
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14791,439,1.13 [0.91-1.39],0.2739964081489737
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,22703,30,1.44 [0.70-2.97],0.3210539012518087
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14960,608,1.03 [0.86-1.24],0.7540248050658617
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21059,153,1.06 [0.73-1.54],0.7493803996477568
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Recurring oral aphthae,22731,49,1.22 [0.65-2.29],0.5336394728953315
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,21951,99,0.91 [0.56-1.47],0.6975623141580853
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Toxic colitis,21004,78,0.53 [0.30-0.95],0.0333604715587575
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16048,333,0.80 [0.62-1.05],0.1082248667541877
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcerative colitis,21093,167,0.94 [0.65-1.35],0.7442510272069167
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21061,135,0.88 [0.58-1.34],0.559560950383889
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Umbilical hernia,17360,255,0.88 [0.66-1.19],0.4101761093305786
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14588,236,0.81 [0.59-1.11],0.1878142922575137
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ventral hernia,17396,291,1.22 [0.95-1.57],0.124172326908476
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Volvulus,14446,94,0.51 [0.30-0.88],0.0142552439252172
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,22637,410,0.94 [0.74-1.18],0.5769266506689849
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22385,65,1.12 [0.64-1.96],0.6844476405836376
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20229,158,0.83 [0.56-1.22],0.3496028237303105
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22123,805,1.10 [0.94-1.29],0.2443078363166295
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21455,137,0.98 [0.66-1.46],0.9284380234607564
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,20689,618,0.97 [0.80-1.17],0.7237732121049979
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22408,315,0.91 [0.70-1.19],0.4867688598260891
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22646,553,0.94 [0.77-1.15],0.5403582872461671
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22140,47,1.26 [0.67-2.37],0.4647821934715826
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21170,3666,0.95 [0.88-1.02],0.1691600352575658
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22309,436,0.98 [0.78-1.23],0.8582205757687897
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22179,306,0.98 [0.75-1.28],0.8645617020803411
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22364,1046,1.15 [1.00-1.32],0.0561998630961205
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",22721,61,0.98 [0.54-1.78],0.9600981506506078
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20127,56,0.44 [0.22-0.88],0.0203227252434435
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,21934,61,0.79 [0.42-1.48],0.4640633084533784
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22395,302,0.88 [0.67-1.16],0.3497795551648512
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20662,591,0.76 [0.62-0.93],0.0086007124557467
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20158,87,1.22 [0.77-1.95],0.3920819585795686
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,22655,93,1.35 [0.87-2.09],0.1798051742634689
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21553,235,1.20 [0.90-1.61],0.2077794162300361
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22539,219,0.95 [0.70-1.31],0.7739653901693266
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22186,93,1.42 [0.93-2.18],0.1039521151428213
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20148,77,0.89 [0.51-1.53],0.6656185204516121
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22142,2071,0.92 [0.83-1.02],0.1310346403496357
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20706,635,0.78 [0.64-0.94],0.0101410976204276
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20162,91,1.20 [0.76-1.90],0.4245693799376503
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22652,332,0.93 [0.72-1.20],0.5683223149482961
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22166,73,0.54 [0.30-0.99],0.0446536237581852
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22590,270,0.89 [0.67-1.19],0.4332618062539876
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22669,442,0.88 [0.70-1.10],0.2649230044447525
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20189,118,0.85 [0.54-1.32],0.4715622844003407
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20410,339,0.93 [0.72-1.20],0.553377563443691
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22657,430,0.89 [0.71-1.13],0.342686008561575
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20397,326,0.96 [0.74-1.24],0.7419635008271488
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,22713,151,1.20 [0.84-1.72],0.315930882655063
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,18941,76,0.82 [0.47-1.42],0.4760012165741065
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20034,6332,0.92 [0.87-0.98],0.0057532020430667
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18645,4943,0.89 [0.84-0.96],0.0014444243200746
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,18917,52,1.15 [0.62-2.15],0.6517429791341391
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18845,144,0.98 [0.66-1.45],0.916962172345921
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18889,188,1.11 [0.80-1.54],0.547252218228591
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22484,63,1.14 [0.65-1.99],0.6430739550133072
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",18853,152,1.05 [0.72-1.53],0.7985101745438221
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15155,1453,0.88 [0.77-1.00],0.0423083856962237
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22528,240,0.96 [0.71-1.31],0.8182713175438486
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19280,579,1.00 [0.83-1.22],0.9825925934957074
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18391,7908,0.92 [0.87-0.97],0.0024218589384274
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20233,115,1.00 [0.65-1.53],0.9828266499223612
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19044,179,1.19 [0.85-1.66],0.309021697438418
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19363,498,0.88 [0.71-1.10],0.2585209196196871
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21810,3109,0.96 [0.88-1.04],0.3437530147454536
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19168,303,0.57 [0.42-0.76],0.0001658064070581
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19009,144,0.66 [0.43-1.00],0.0505897221039888
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,18982,117,0.79 [0.50-1.23],0.2948737265127485
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22011,97,1.06 [0.66-1.70],0.809372974307063
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15683,1981,0.88 [0.79-0.98],0.0225280596620245
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14487,785,1.05 [0.89-1.24],0.5560327153736437
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22644,778,1.09 [0.93-1.28],0.2953290290138164
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,13777,75,0.99 [0.58-1.68],0.9568961548154096
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),13996,294,0.97 [0.74-1.28],0.841368372562166
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19127,262,0.80 [0.59-1.08],0.1499270435407758
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14174,472,0.79 [0.63-0.99],0.0440027940969065
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,18783,82,0.98 [0.58-1.65],0.9378309073509136
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19383,682,1.12 [0.94-1.33],0.2130555642571008
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19013,312,1.06 [0.82-1.37],0.675697476172594
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14146,444,0.78 [0.62-0.98],0.035960372390335
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,18936,71,0.99 [0.57-1.72],0.962412845622938
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",18925,60,1.18 [0.66-2.10],0.5782589373355246
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20204,86,1.22 [0.77-1.94],0.4009439699011996
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22313,2195,0.88 [0.80-0.98],0.0193236704154367
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21664,1546,0.85 [0.75-0.96],0.008819104715471
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22569,530,1.08 [0.89-1.32],0.4249432623845691
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16777,3075,0.88 [0.81-0.96],0.0033930283910353
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,13745,43,0.56 [0.26-1.24],0.1533020942337261
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,18971,106,0.98 [0.62-1.54],0.9315086186720856
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,13769,67,1.12 [0.64-1.98],0.6854546359715665
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),13833,131,0.79 [0.51-1.22],0.2854842839785031
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20354,236,1.09 [0.81-1.46],0.5672776684045469
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,20619,501,0.86 [0.69-1.06],0.1628658603905053
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,22718,109,0.81 [0.50-1.29],0.3731232030184573
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20663,1962,1.00 [0.90-1.11],0.9980372985486478
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,18937,72,1.32 [0.81-2.14],0.2608693553076294
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),13853,151,0.78 [0.52-1.17],0.2262479999253498
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19475,774,0.98 [0.83-1.16],0.8558799981852478
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15856,2154,0.90 [0.81-1.00],0.0498298675025423
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22035,121,1.12 [0.74-1.69],0.5886285094095239
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,22729,62,1.14 [0.65-2.01],0.6489634617806888
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,18942,77,0.66 [0.37-1.17],0.1545182691396289
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20196,1331,0.97 [0.85-1.11],0.6621946137242223
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,18970,105,1.40 [0.93-2.10],0.1067409021492786
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15747,2045,0.88 [0.79-0.98],0.0190477897542654
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20232,114,1.08 [0.71-1.65],0.7117963239207331
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,18903,38,1.14 [0.56-2.33],0.715748885998465
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,18892,191,0.87 [0.62-1.24],0.4503159351124055
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19543,678,0.92 [0.77-1.11],0.4002042064842936
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22395,481,1.04 [0.84-1.29],0.6899009904147273
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19356,655,1.04 [0.87-1.24],0.677493839472219
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22584,524,1.10 [0.90-1.34],0.3434513295200666
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,22715,67,1.20 [0.71-2.04],0.5001957241920286
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19025,160,1.03 [0.71-1.48],0.8934331680055809
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17679,879,1.05 [0.90-1.23],0.5165129856543341
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19499,634,1.13 [0.94-1.35],0.1859339963829855
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19138,273,0.54 [0.39-0.73],8.912606241077307e-05
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",13772,70,0.58 [0.31-1.07],0.0796403405263928
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16777,3075,0.93 [0.85-1.01],0.0814520757050071
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14520,818,0.92 [0.78-1.09],0.3559113935054113
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22283,369,1.10 [0.86-1.39],0.4432498765084229
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",22688,79,0.70 [0.40-1.24],0.2251577611999345
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20120,67,0.91 [0.51-1.62],0.7416338194000516
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,13765,63,1.06 [0.60-1.89],0.8404281650638041
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,18809,108,0.84 [0.53-1.34],0.469323646293692
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14240,538,1.06 [0.87-1.29],0.5459588447347871
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19197,332,0.64 [0.49-0.84],0.0015135450470548
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,18986,285,1.04 [0.79-1.36],0.7795438554932412
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,18968,267,0.84 [0.62-1.13],0.2507063249614197
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15976,67,1.36 [0.84-2.21],0.2138161512684451
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",22720,72,1.22 [0.74-2.03],0.4382295520837754
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19410,545,0.81 [0.66-1.00],0.0482151412546477
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22003,89,0.75 [0.44-1.27],0.2891598206717807
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21462,2597,0.89 [0.81-0.97],0.011657725265316
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19011,146,0.72 [0.47-1.08],0.1153821773133427
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19402,701,0.98 [0.82-1.17],0.8115902761652056
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21401,268,0.94 [0.70-1.25],0.6497181351298813
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,18949,248,1.23 [0.93-1.62],0.1467382437064791
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20677,1976,0.92 [0.83-1.02],0.1296217763979244
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,19995,1294,0.93 [0.81-1.06],0.2515151711208759
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],18928,63,0.92 [0.50-1.67],0.7720690970417478
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22027,113,0.99 [0.64-1.53],0.9685567247905073
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19023,158,0.89 [0.60-1.30],0.5415837825718628
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,18954,89,0.72 [0.42-1.23],0.2355420472670127
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),13779,77,0.86 [0.50-1.50],0.6027027723899374
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21252,2220,1.13 [1.02-1.24],0.0157912887028816
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9088,25,0.46 [0.16-1.32],0.1496984766010243
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11536,33,0.62 [0.25-1.51],0.2933287376127079
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22411,312,1.20 [0.94-1.53],0.1475664210523821
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22205,106,1.42 [0.95-2.12],0.0868656938451388
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21333,2301,1.21 [1.10-1.33],8.233731230016759e-05
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22511,131,1.13 [0.77-1.68],0.5273667599908328
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22437,398,1.14 [0.91-1.42],0.2660222920476429
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cystitis,18951,295,0.95 [0.72-1.25],0.7113002495526789
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Dialysis,19127,95,1.65 [1.10-2.47],0.0155512647195143
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10029,2107,0.95 [0.86-1.06],0.3616720719001884
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11637,134,0.69 [0.45-1.07],0.1000858717337634
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Endometriosis,9102,39,0.62 [0.27-1.41],0.2508241884282529
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9636,573,0.93 [0.76-1.14],0.5044205733726008
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18719,6189,1.03 [0.97-1.09],0.332278882059373
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22476,96,1.07 [0.67-1.69],0.7888292848350145
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hydrocele,8040,118,0.99 [0.65-1.51],0.9735729519410168
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19101,347,1.00 [0.77-1.28],0.981053449366574
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9719,1797,0.93 [0.83-1.04],0.1806154845437926
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11701,160,0.88 [0.60-1.29],0.5054043345850472
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8045,123,0.93 [0.61-1.42],0.7514274679994699
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18741,85,1.02 [0.61-1.71],0.925144958082566
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10085,1022,0.99 [0.85-1.15],0.8780121572827374
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,7981,59,1.09 [0.61-1.96],0.7698257778499512
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9102,39,1.37 [0.68-2.75],0.3799836828545775
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",22726,85,0.78 [0.46-1.33],0.3665271614978412
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",22727,81,0.98 [0.58-1.65],0.9315393630630204
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21560,2904,1.00 [0.92-1.09],0.9910730943564806
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19587,931,1.04 [0.90-1.22],0.5697589774519407
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11554,51,0.51 [0.25-1.06],0.0730384115596379
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22659,620,1.11 [0.93-1.33],0.2631571054345433
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8073,151,0.87 [0.59-1.28],0.4833594571523113
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8084,162,0.93 [0.64-1.33],0.6768620845851012
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8073,151,0.83 [0.56-1.22],0.3402401436631906
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,22702,87,0.93 [0.56-1.54],0.7669161443413276
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,20959,2303,0.99 [0.90-1.10],0.8832651959919211
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11624,83,0.79 [0.46-1.36],0.4026794890886449
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9128,65,1.16 [0.67-1.99],0.5936797839537278
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9202,139,1.12 [0.76-1.66],0.5671362048475144
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9115,52,0.93 [0.48-1.80],0.8282363878759524
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9160,97,1.01 [0.62-1.62],0.9805358324668376
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19162,408,1.05 [0.83-1.32],0.6991107918753845
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22237,198,1.01 [0.73-1.41],0.9303097576802888
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9188,125,1.02 [0.67-1.55],0.9207756141585904
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9088,25,1.63 [0.80-3.33],0.1771077392892266
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9272,209,1.16 [0.85-1.59],0.3442493756845149
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9157,94,1.00 [0.61-1.63],0.9985519936513996
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9266,203,0.95 [0.68-1.33],0.7818555371247367
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22424,44,1.23 [0.63-2.41],0.5475777274232152
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8076,154,0.96 [0.66-1.39],0.8353161269483471
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22455,3701,1.14 [1.05-1.22],0.0009042959559317
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",18848,94,1.05 [0.65-1.68],0.8524516498375532
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19210,178,1.50 [1.10-2.05],0.0114629520702799
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22138,39,1.44 [0.77-2.70],0.2500938098695147
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18918,262,0.97 [0.73-1.30],0.8361364655133801
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22497,398,1.26 [1.02-1.56],0.0345708504810143
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9098,35,1.56 [0.80-3.04],0.1955801260798713
